Florent Mouliere Selected Research

Cell-Free Nucleic Acids

1/2022	Refined characterization of circulating tumor DNA through biological feature integration.
1/2022	Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.
1/2022	Cell-free DNA technologies for the analysis of brain cancer.
11/2021	PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based Approach.
1/2021	Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients.
1/2020	Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations.
10/2019	Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
1/2019	Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models.
12/2018	Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.
11/2018	Enhanced detection of circulating tumor DNA by fragment size analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Florent Mouliere Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 10/2010
7	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 10/2010
4	Glioma (Gliomas) 01/2022 - 11/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2020
2	Disease Progression 01/2020 - 08/2018
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Adenocarcinoma 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Residual Neoplasm 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018
1	Melanoma (Melanoma, Malignant) 08/2018
1	Necrosis 06/2012

Drug/Important Bio-Agent (IBA)

19	Cell-Free Nucleic AcidsIBA 01/2022 - 10/2010
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2014
5	Circulating Tumor DNAIBA 01/2022 - 08/2018
2	ChromatinIBA 01/2022 - 10/2019
1	Single-Stranded DNA (DNA, Single Stranded)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Nucleosomes (Nucleosome)IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 11/2021
1	LithiumIBA 11/2021
1	Edetic Acid (EDTA)FDA Link 11/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 06/2012

Therapy/Procedure

6	Therapeutics 01/2020 - 10/2010
3	Precision Medicine 07/2014 - 06/2012
1	Radiotherapy 01/2020